Cross-reactive HIV-1 neutralizing monoclonal antibodies selected by screening of an immune human phage library against an envelope glycoprotein (gp140) isolated from a patient (R2) with broadly HIV-1 neutralizing antibodies-Reference-Cited by-同舟云学术

Cross-reactive HIV-1 neutralizing monoclonal antibodies selected by screening of an immune human phage library against an envelope glycoprotein (gp140) isolated from a patient (R2) with broadly HIV-1 neutralizing antibodies

Published:2007-06 Issue:1 Volume:363 Page:79-90
ISSN:0042-6822
Container-title:Virology
language:en
Short-container-title:Virology

Author:

Choudhry Vidita,Zhang Mei-Yun,Sidorov Igor A.,Louis John M.,Harris Ilia,Dimitrov Antony S.,Bouma Peter,Cham Fatim,Choudhary Anil,Rybak Susanna M.,Fouts Timothy,Montefiori David C.,Broder Christopher C.,Quinnan Gerald V.,Dimitrov Dimiter S.

Publisher

Elsevier BV

Subject

Virology

Reference43 articles.

1. Phage Display: A Laboratory Manual;Barbas,2001

2. Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies;Binley;J. Virol.,2004

3. Immunization with recombinant canarypox vectors expressing membrane-anchored glycoprotein 120 followed by glycoprotein 160 boosting fails to generate antibodies that neutralize R5 primary isolates of human immunodeficiency virus type 1;Bures;AIDS Res. Hum. Retroviruses,2000

4. Regional clustering of shared neutralization determinants on primary isolates of clade C human immunodeficiency virus type 1 from South Africa;Bures;J. Virol.,2002

5. Antibodies, viruses and vaccines;Burton;Nat. Rev., Immunol.,2002

Cited by 63 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Early rhombic lip Protogenin+ve stem cells in a human-specific neurovascular niche initiate and maintain group 3 medulloblastoma;Cell;2024-08

2. Natural Variation in HIV-1 Entry Kinetics Map to Specific Residues and Reveal an Interdependence Between Attachment and Fusion;2024-06-25

3. Identification of Anti-gp41 Monoclonal Antibodies That Effectively Target Cytotoxic Immunoconjugates to Cells Infected with Human Immunodeficiency Virus, Type 1;Vaccines;2023-04-12

4. Therapeutic Protein-Based Vaccines;Protein-based Therapeutics;2023

5. Developing Recombinant Antibodies by Phage Display Against Infectious Diseases and Toxins for Diagnostics and Therapy;Frontiers in Cellular and Infection Microbiology;2021-07-07